The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 17 , ISSUE 4 ( April, 2016 ) > List of Articles

REVIEW ARTICLE

Chemical Plaque Control Strategies in the Prevention of Biofilm-associated Oral Diseases

Sukumaran Anil, Elna P Chalisserry, Mohammed Jafer, Jagadish Hosmani

Citation Information : Anil S, Chalisserry EP, Jafer M, Hosmani J. Chemical Plaque Control Strategies in the Prevention of Biofilm-associated Oral Diseases. J Contemp Dent Pract 2016; 17 (4):337-343.

DOI: 10.5005/jp-journals-10024-1851

Published Online: 01-09-2016

Copyright Statement:  Copyright © 2016; The Author(s).


Abstract

How to cite this article

Jafer M, Patil S, Hosmani J, Bhandi SH, Chalisserry EP, Anil S. Chemical Plaque Control Strategies in the Prevention of Biofilm-associated Oral Diseases. J Contemp Dent Pract 2016;17(4):337-343.


PDF Share
  1. A four-point scale for selection of caries risk patients, based on salivary S. mutans levels and plaque formation rate index.Johnson, NW., editor. Risk markers for oral diseases caries, Vol. 1. Cambridge, MA: Cambridge University Press; 1991. p. 158-170.
  2. Biofilms, the customized microniche. J Bacteriol 1994 Apr;176(8):2137-2142.
  3. Bacterial interactions in dental biofilm development. J Dent Res 2009 Nov;88(11):982-990.
  4. Preventive materials, methods, and programs. Hanover Park: Quintessence Pub; 2004.
  5. Chemotherapy of dental plaque infections. Oral Sci Rev 1975;9:65-107.
  6. The non-specific theory in microbial etiology of inflammatory periodontal diseases. J Clin Periodontol 1986 Nov;13(10):905-911.
  7. Host defenses and microbial homeostasis-role of microbial interactions. J Dent Res 1989;68:1567-1575.
  8. Effect of self-performed mechanical plaque control frequency on gingival inflammation revisited: a randomized clinical trial. J Clin Periodontol 2016 Apr;43(4):354-358.
  9. Oral biofilm-associated diseases: trends and implications for quality of life, systemic health and expenditures. Periodontol 2000 2011 Feb;55(1):87-103.
  10. Controlling the oral biofilm with antimicrobials. J Dent 2010 Jun;38 Suppl 1:S11-S15.
  11. Contemporary perspective on plaque control. Br Dent J 2012 Jun 22;212(12):601-606.
  12. In vitro evidence for efficacy of antimicrobial mouthrinses. J Dent 2010 Jun;38 Suppl 1:S16-S20.
  13. The rationale for the daily use of an antimicrobial mouthrinse. J Am Dent Assoc 2006 Nov;137 Suppl:16S-21S.
  14. The effects of triclosan and zinc citrate, alone and in combination, on a community of oral bacteria grown in vitro. J Dent Res 1993 Jan;72(1):25-30.
  15. Intraplaque acid formation assessed in vivo in children and young adults. Pediatr Dent 1980;2(2)87-93.
  16. On the mechanism of the plaque inhibition by chlorhexidine. J Dent Res 1975 Jun;54 Spec No B:B57-B62.
  17. Response of single species biofilms and microcosm dental plaques to pulsing with chlorhexidine. J Antimicrob Chemother 1998 Oct;42(4):453-459.
  18. Validation of an in vitro biofilm model of supragingival plaque. J Dent Res 2001 Jan;80(1):363-370.
  19. Ultrastructure, growth, and adherence of Streptococcus mutans after treatment with chlorhexidine and fluoride. Caries Res 1988;22(5)283-287.
  20. An in vitro oral biofilm model for comparing the efficacy of antimicrobial mouthrinses. Caries Res 2002 Mar-Apr;36(2):93-100.
  21. The effect of mouthrinses and topical application of chlorhexidine on the development of dental plaque and gingivitis in man. J Periodontal Res 1970;5(2)79-83.
  22. Effects of supervised chlorhexidine mouthrinses in children. A longitudinal clinical trial. J Periodontal Res 1982 Jan;17(1):101-111.
  23. A comparative study of the bactericidal and growth inhibitory activities of the bisbiguanides alexidine and chlorhexidine. J Appl Bacteriol 1989 Mar;66(3):243-252.
  24. Antimicrobial effect of a chlorhexidine-thymol varnish (Cervitec) in orthodontic patients. A prospective, randomized clinical trial. J Orofac Orthop 1997;58(4)206-213.
  25. Chlorhexidine varnishes: a review. J Clin Periodontol 2002 Jan;29(1):1-8.
  26. Six-month study of the effects of a chlorhexidine mouthrinse on gingivitis in adults. J Periodontal Res 1986 Nov;21(s16):33-43.
  27. Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. J Clin Periodontol 1990 Sep;17(8):575-579.
  28. Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months. Oral Dis 1998 Jun;4(2):105-113.
  29. 6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis. J Clin Periodontol 1998 Sep;25(9):746-753.
  30. Modes of action of currently known chemical anti-plaque agents other than chlorhexidine. J Dental Res 1989;68:1609-1616.
  31. Evaluation of microbial shifts following long-term antiseptic mouthrinse use. J Dent Res 1989;68:412.
  32. Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol 2004 Oct;31(10):878-884.
  33. The effect of Listerine antiseptic on reduction of existing plaque and gingivitis. Clin Prev Dent 1983;5(6)12-16.
  34. Adjunctive benefit of an essential oil-containing mouthrinse in reducing plaque and gingivitis in patients who brush and floss regularly: a six-month study. J Am Dent Assoc 2004 Apr;135(4):496-504.
  35. Long-term efficacy of a 0.07% cetylpyridinium chloride mouth rinse in relation to plaque and gingivitis: a 6-month randomized, vehiclecontrolled clinical trial. Int J Dent Hyg 2015 May;13(2):93-103.
  36. Int J Dent Hyg 2008 Nov;6(4):290-303.
  37. Safety and efficacy of antimicrobial mouthrinses in clinical practice. Am Dent Hyg Assoc 2007; 81Suppl 1:117-117.
  38. Comparative efficacy of two daily use mouthrinses: randomized clinical trial using an experimental gingivitis model. Braz Oral Res 2011 Jul-Aug;25(4):338-344.
  39. Are dental diseases examples of ecological catastrophes? Microbiology 2003 Feb;149(Pt 2):279-294.
  40. A six-month clinical study of the effect of a pre-brush rinse on plaque removal and gingivitis. Br Dent J 1993 Nov 6;175(9):322-326.
  41. Effect on plaque removal and gingivitis of a triclosan-copolymer prebrush rinse: a six-month clinical study in Canada. J Can Dent Assoc 1995 Jan;61(1):53-56, 59-61.
  42. Effect of a triclosan/copolymer pre-brush mouthrinse on established plaque formation and gingivitis: a six-month clinical study in Thailand. J Clin Dent 1995;6(2)142-147.
  43. The effect of mouthrinses containing zinc and triclosan on plaque accumulation, development of gingivitis and formation of calculus in a 28-week clinical test. J Clin Periodontol 1996 May;23(5):465-470.
  44. Randomized controlled clinical trials on agents used for chemical plaque control. Int J Dent Hyg 2005 Nov;3(4):162-178.
  45. Effects of 6 months use of an antiseptic mouthrinse on supragingival dental plaque microflora. J Clin Periodontol 1989 Jul;16(6):347-352.
  46. Effect of delmopinol on in vitro dental plaque formation, bacterial acid production and the number of microorganisms in human saliva. Oral Microbiol Immunol 1991 Oct;6(5):305-309.
  47. A 6-month home-usage trial of 0.1% and 0.2% delmopinol mouthwashes (I). Effects on plaque, gingivitis, supragingival calculus and tooth staining. J Clin Periodontol 1996 Mar;23(3 Pt 1):220-228.
  48. Short-term effect of topical application of delmopinol on salivary microbiology, plaque, and gingivitis. Scand J Dent Res 1994 Feb;102(1):17-23.
  49. Microbiology of early supragingival plaque development after delmopinol treatment. Oral Microbiol Immunol 1993 Feb;8(1):36-41.
  50. The effect of povidone iodine on plaque and salivary bacteria. A double-blind crossover trial. J Periodontol 1977 Nov;48(11):730-732.
  51. The effect of a povidoneiodine mouthwash upon thyroid function and plaque accumulation. Br Dent J 1978 Jan 3;144(1):14-16.
  52. Dextranase in sugar industry: a review. Sugar Tech 2009;11(2)124-134.
  53. Dextran-induced agglutination of S. mutans, and its potential role in the formation of microbial dental plaques. J Bacteriol 1969 May;98(2):341-346.
  54. Degradation of dental plaque glucans and prevention of glucan formation using commercial enzymes. Process Biochem 2002;38(1)101-108.
  55. Microbial dextran-hydrolyzing enzymes: fundamentals and applications. Microbiol Mol Biol Rev 2005 Jun;69(2):306-325.
  56. Optimization of sugarcane factory application of commercial dextranases. Process Biochem 2005;40(5):1881-1894.
  57. Characterization of an extracellular dextranase from Fusarium moniliforme. Appl Microbiol 1975 Nov;30(5):855-861.
  58. Characterization of a marine-derived dextranase and its application to the prevention of dental caries. J Ind Microbiol Biotechnol 2014 Jan;41(1):17-26.
  59. A study to investigate the effect of a propolis-containing mouthrinse on the inhibition of de novo plaque formation. J Clin Periodontol 1997 Nov;24(11):796-798.
  60. Antimicrobial activity of the essential oil from Lippia sidoides, carvacrol and thymol against oral pathogens. Braz J Med Biol Res 2007 Mar;40(3):349-356.
  61. Effect of Lippia sidoides in mouthrinses on de novo plaque formation: a double-blind clinical study in humans. Indian J Dent Res 2013 Sep-Oct;24(5):533-536.
  62. Antiplaque and antigingivitis effect of Lippia Sidoides: a double-blind clinical study in humans. J Appl Oral Sci 2009 Sep-Oct;17(5):404-407.
  63. Comparative evaluation of anti-plaque efficacy of herbal and 0.2% chlorhexidine gluconate mouthwash in a 4-day plaque re-growth study. J Indian Soc Periodontol 2013 Jan;17(1):72-77.
  64. Preliminary antiplaque efficacy of Aloe vera mouthwash on 4 day plaque re-growth model: randomized control trial. Ethiop J Health Sci 2014 Apr;24(2):139-144.
  65. Effect of Aloe vera mouthwash on periodontal health: triple blind randomized control trial. Oral Health Dent Manag 2014 Mar;13(1):14-19.
  66. The antimicrobial potential of 14 natural herbal dentifrices: results of an in vitro diffusion method study. J Am Dent Assoc 2004 Aug;135(8):1133-1141.
  67. Caries ecology revisited: microbial dynamics and the caries process. Caries Res 2008;42(6)409-418.
  68. Chlorhexidine affects arginine metabolism as well as glycolysis in a strain of Streptococcus sanguis. Oral Microbiol Immunol 1987 Dec;2(4):172-182.
  69. Effects of mouthrinses containing essential oils and alcoholfree chlorhexidine on human plaque acidogenicity. Clin Oral Investig 2010 Feb;14(1):107-112.
  70. Effect of an essential oil mouthrinse, with and without fluoride, on plaque metabolic acid production and pH after a sucrose challenge. Caries Res 2004 Nov-Dec;38(6):537-541.
  71. Zinc citrate/Triclosan: a new anti-plaque system for the control of plaque and the prevention of gingivitis: shortterm clinical and mode of action studies. J Clin Periodontol 1991 Jul;18(6):455-461.
  72. Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofilm. J Clin Periodontol 2008 Sep;35 Suppl 8:45-66.
  73. Biological plaque control: novel therapeutic approach to periodontal disease. J Oral Sci 2012 Mar;54(1):1-5.
  74. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol Immunol 2005 Dec;20(6):354-361.
  75. Short-term effect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid. Acta Odontol Scand 2009;67(1)19-24.
  76. Passive transfer of immunoglobulin Y antibody to S. mutans glucan binding protein B can confer protection against experimental dental caries. Infect Immun 2001 May;69(5):3135-3142.
  77. Natural products in caries research: current (limited) knowledge, challenges and future perspective. Caries Res 2011;45(3)243-263.
  78. Chemical and mechanical removal of plaque. Compend Contin Educ Dent 1985;Suppl6:S110-S116.
  79. Chemotherapeutic agents for controlling plaque and gingivitis. J Clin Periodontol 1988 Sep;15(8):488-498.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.